Echinocandin
Echinocandin — A class of cyclic lipopeptide antifungal agents that inhibit glucan synthesis in fungal cell walls, an example of peptide-based antimicrobial compounds.
What Is an Echinocandin?
Echinocandins are a class of lipopeptide antifungal drugs that inhibit β-(1,3)-D-glucan synthase, an enzyme essential for fungal cell wall biosynthesis. Caspofungin, micafungin, and anidulafungin are FDA-approved echinocandins used as first-line therapy for invasive Candida and Aspergillus infections.
Features
- Structure: Cyclic hexapeptide with N-linked fatty acid tail
- Selectivity: Target fungal-specific enzyme (β-glucan synthase). No mammalian equivalent. Excellent safety profile
- Route: IV only (poor oral absorption). Once-daily dosing
Frequently Asked Questions
What is Echinocandin?
A class of cyclic lipopeptide antifungal agents that inhibit glucan synthesis in fungal cell walls, an example of peptide-based antimicrobial compounds.
Why is Echinocandin important in peptide research?
Echinocandin is a fundamental concept in compound as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.